Previous Article |
Table of Contents
| Next Article
BIOLOGICAL SCIENCES / MEDICAL SCIENCES
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet
cell microchimerism
,
,











Human Immunogenetics and 
Clinical Statistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109;
Department of Medicine, 1959 NE Pacific Street, University of Washington, Seattle, WA 98195; ¶Diabetes and Metabolism, Department of Clinical Science at North Bristol, University of Bristol, Southmead Hospital, Bristol BS10 5NB, United Kingdom; ||Laboratoire Inserm, U639, Faculté de Medicine Timone, 27 Boulevard Jean Moulin, 13385 Marseille, France; and 
Pediatric Rheumatology and 
Department of Pathology, Children's Regional Hospital and Medical Center, 4800 Sand Point Way, Seattle, WA 98105
Edited by Johannes van Rood, Europdonor Foundation, Leiden, The Netherlands, and approved December 5, 2006 (received for review July 20, 2006)
Maternal cells have recently been found in the circulation and tissues of mothers' immune-competent children, including in adult life, and is referred to as maternal microchimerism (MMc). Whether MMc confers benefits during development or later in life or sometimes has adverse effects is unknown. Type 1 diabetes (T1D) is an autoimmune disease that primarily affects children and young adults. To identify and quantify MMc, we developed a panel of quantitative PCR assays targeting nontransmitted, nonshared maternal-specific HLA alleles. MMc was assayed in peripheral blood from 172 individuals, 94 with T1D, 54 unaffected siblings, and 24 unrelated healthy subjects. MMc levels, expressed as the genome equivalent per 100,000 proband cells, were significantly higher in T1D patients than unaffected siblings and healthy subjects. Medians and ranges, respectively, were 0.09 (0530), 0 (0153), and 0 (07.9). Differences between groups were evident irrespective of HLA genotypes. However, for patients with the T1D-associated DQB1*0302-DRB1*04 haplotype, MMc was found more often when the haplotype was paternally (70%) rather than maternally transmitted (14%). In other studies, we looked for female islet
cells in four male pancreases from autopsies, one from a T1D patient, employing FISH for X and Y chromosomes with concomitant CD45 and
cell insulin staining. Female islet
cells (presumed maternal) formed 0.390.96% of the total, whereas female hematopoietic cells were very rare. Thus, T1D patients have higher levels of MMc in their circulation than unaffected siblings and healthy individuals, and MMc contributes to islet
cells in a mother's progeny.
quantitative PCR | chimerism | autoimmunity | pancreas | HLA
The authors declare no conflict of interest.
This article is a PNAS direct submission.
This article contains supporting information online at www.pnas.org/cgi/content/full/0606169104/DC1.
To whom correspondence should be addressed at: Immunogenetics D2-100, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109-1024. E-mail: nelsonlab{at}fhcrc.org
© 2007 by The National Academy of Sciences of the USA
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
E. C. Su, K. L. Johnson, H. Tighiouart, and D. W. Bianchi Murine Maternal Cell Microchimerism: Analysis Using Real-Time PCR and In Vivo Imaging Biol Reprod, May 1, 2008; 78(5): 883 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Muraji, N. Hosaka, N. Irie, M. Yoshida, Y. Imai, K. Tanaka, Y. Takada, S. Sakamoto, H. Haga, and S. Ikehara Maternal Microchimerism in Underlying Pathogenesis of Biliary Atresia: Quantification and Phenotypes of Maternal Cells in the Liver Pediatrics, March 1, 2008; 121(3): 517 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Chen, M.-Y. Lee, J.-P. Huang, J. D. Aplin, Y.-H. Wu, C.-S. Hu, P.-C. Chen, H. Li, S.-M. Hwang, S.-H. Liu, et al. Trafficking of Multipotent Mesenchymal Stromal Cells from Maternal Circulation Through the Placenta Involves Vascular Endothelial Growth Factor Receptor-1 and Integrins Stem Cells, February 1, 2008; 26(2): 550 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Feitsma, J. Worthington, A. H. M. van der Helm-van Mil, D. Plant, W. Thomson, J. Ursum, D. van Schaardenburg, I. E. van der Horst-Bruinsma, J. J. van Rood, T. W. J. Huizinga, et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development PNAS, December 11, 2007; 104(50): 19966 - 19970. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Butler, A. Huang, P. N. Rao, A. Bhushan, W. J. Hogan, R. A. Rizza, and P. C. Butler Hematopoietic Stem Cells Derived From Adult Donors Are Not a Source of Pancreatic {beta}-Cells in Adult Nondiabetic Humans Diabetes, July 1, 2007; 56(7): 1810 - 1816. [Abstract] [Full Text] [PDF] |
||||